SMTIN-P01
SMTIN-P01 is a TRAP1 inhibitor that is selective for cytosolic Hsp90 and accumulates in mitochondria. SMTIN-P01 binds to the ATP-binding site of TRAP1 as an ATP mimic, thereby inhibiting ATPase and foldase activities. SMTIN-P01 induces mitochondrial membrane depolarization and proteolytic degradation in cancer cells. SMTIN-P01 exhibits significant cytotoxicity, but shows extremely low toxicity to primary mouse hepatocytes, and does not interfere with SIRT3-related functions or the levels of cytosolic Hsp90 substrates. SMTIN-P01 has important application value in cancer-related research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1695550-43-6
- 分子式: C36H34BrIN5O2PS
- 分子量:838.53
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
|
HSP90 |
体外実験
SMTIN-P01 (1-6 μM; 30 min preincubation, 3 h ATP incubation) inhibits the ATPase activity of purified recombinant human TRAP1 in a concentration-dependent manner, with greater activity than gamitrinib[1].
SMTIN-P01 (10 μM; 30 min at 37 °C) induces mitochondrial membrane depolarization in human cervical cancer HeLa cells, indicating disruption of mitochondrial function[1].
SMTIN-P01 (2 μM; 24 h at 37 °C) does not induce canonical Hsp90 inhibition responses (Hsp70 upregulation, client protein depletion) in human 22Rv1, HeLa, or H460 cancer cells, indicating a mitochondria-specific mode of action distinct from non-targeted Hsp90 inhibitors[1].
SMTIN-P01 (5-20 μM; 24 h at 37 °C) potently reduces viability of multiple human cancer cell lines (ACHN, HeLa, SK-OV3, 22Rv1, SK-HEP-1, A172, H460, MDA-MB-231) in a concentration-dependent manner, with greater cytotoxicity than PU-H71 and improved activity over gamitrinib in several cancer cell lines, while showing minimal toxicity to normal human corneal cells[1].
SMTIN-P01 is a mitochondria-targeted TRAP1 inhibitor that binds the TRAP1 N-terminal domain ATP binding site, induces TRAP1 client protein degradation in cancer cells, and does not elicit Hsp90-related off-target effects or heat shock responses[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human prostate cancer 22Rv1 cells, human cervical cancer HeLa cells, human lung cancer H460 cells
-
Concentration:2 μM
-
Incubation Time:24 h at 37 °C
-
Result:Did not induce upregulation of Hsp70 or depletion of the Hsp90 client proteins Chk1 and Akt, in contrast to the effects of the non-targeted Hsp90 inhibitor PU-H71.
-
Cell Line:human cancer cell lines (ACHN, HeLa, SK-OV3, 22Rv1, SK-HEP-1, A172, H460, MDA-MB-231), normal human corneal cells
-
Concentration:5, 10, 15, 20 μM
-
Incubation Time:24 h at 37 °C
-
Result:Reduced viability of all tested cancer cell lines in a concentration-dependent manner.
Showed stronger cytotoxicity than PU-H71 across all cancer cell lines, and significantly stronger cytotoxicity than gamitrinib in 22Rv1, SK-HEP-1, A172, H460, and MDA-MB-231 cells (p < 0.05).
Exhibited minimal cytotoxicity against normal human corneal cells.
化学情報
-
CAS 番号 1695550-43-6
-
分子量 838.53
-
分子式 C36H34BrIN5O2PS
-
SMILES
IC1=C(SC2=NC3=C(N2CCCCCC[P+](C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)N=CN=C3N)C=C7OCOC7=C1.[Br-]
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
純度とドキュメンテーション
参考文献
[1]. Lee C, et al. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1. J Am Chem Soc. 2015;137(13):4358-4367. [Content Brief]
[2]. Serapian SA, et al. Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives. Trends Pharmacol Sci. 2021;42(7):566-576. [Content Brief]
[3]. Kang S, et al. Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1. J Med Chem. 2022;65(24):16155-16172. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)